Back

Choose your region

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
6401 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2015 Experimental Therapy Poland 44,6
6402 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2015 Experimental Therapy Poland 24,3
6403 Cord Tissue Allogeneic – Unrelated Stroke Neurology 2015 Experimental Therapy Poland 62,8
6404 Cord Tissue Allogeneic – Unrelated Stroke Neurology 2015 Experimental Therapy Poland 54,9
6405 Cord Tissue Allogeneic – Unrelated Traumatic Encephalopathy Neurology 2015 Experimental Therapy Poland 20,11
6406 Cord Blood Allogeneic – Related Acute Lymphoblastic Leukemia Hematology 2015 Standard Therapy Poland 4
6407 Cord Blood Autologous Brain Damage Neurology 2015 Experimental Therapy Germany 5
6408 Cord Blood Autologous Hypoxia-Ischemic Encephalopathy (Hie) Neurology 2015 Experimental Therapy UK 6 months
6409 Cord Blood Autologous Neuroblastoma Hematology 2015 Standard Therapy Germany 5
6410 Cord Blood Allogeneic – Related Scid (Severe Combined Immunodeficiency) Hematology 2015 Standard Therapy UK 3 months
6411 Cord Blood Allogeneic – Related Sickle Cell Anemia Hematology 2015 Standard Therapy UK 2,6
6412 Cord Blood Allogeneic – Related Thalassemia Hematology 2015 Standard Therapy UK 12
6413 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2015 Standard Therapy Turkey 3
6414 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2015 Standard Therapy Turkey 2
6415 Bone Marrow Family Allogeneic Chronic Lymphocytic Leukemia Hematology 2015 Standard Therapy Germany 74
6416 Bone Marrow Family Allogeneic Secondary Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 64
6417 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2015 Standard Therapy Germany 23
6418 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 72
6419 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 43
6420 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 63
6421 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 73
6422 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 61
6423 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 33
6424 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 42
6425 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 57
6426 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 37
6427 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 72
6428 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 63
6429 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 66
6430 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 45
6431 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 48
6432 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 59
6433 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2015 Standard Therapy Germany 58
6434 Apheresis Autologous Anaplastic Large Cell Lymphoma Hematology 2015 Standard Therapy Germany 57
6435 Apheresis Autologous Anaplastic T-Cell Lymphoma – Relapse Hematology 2015 Standard Therapy Germany 26
6436 Apheresis Allogeneic Aplastic Anemia – Relapse Hematology 2015 Standard Therapy Germany 53
6437 Apheresis Allogeneic B-Cell Non-Hodgkin Lymphoma Hematology 2015 Standard Therapy Germany 59
6438 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma Hematology 2015 Standard Therapy Germany 48
6439 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma Hematology 2015 Standard Therapy Germany 23
6440 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma Hematology 2015 Standard Therapy Germany 62
6441 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2015 Standard Therapy Germany 51
6442 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2015 Standard Therapy Germany 50
6443 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2015 Standard Therapy Germany 31
6444 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2015 Standard Therapy Germany 57
6445 Apheresis Autologous Ewing Sarcoma Hematology 2015 Standard Therapy Germany 24
6446 Apheresis Autologous Germ Cell Tumor Hematology 2015 Standard Therapy Germany 17
6447 Apheresis Autologous Gray Zone Lymphoma Hematology 2015 Standard Therapy Germany 26
6448 Apheresis Autologous Hodgkin Relapse Hematology 2015 Standard Therapy Germany 29
6449 Apheresis Autologous Lymphoma Hematology 2015 Standard Therapy Germany 53
6450 Apheresis Autologous Mantle Cell Lymphoma Hematology 2015 Standard Therapy Germany 56
6451 Apheresis Autologous Mantle Cell Lymphoma Hematology 2015 Standard Therapy Germany 66
6452 Apheresis Autologous Mantle Cell Lymphoma Hematology 2015 Standard Therapy Germany 53
6453 Apheresis Autologous Mantle Cell Lymphoma Hematology 2015 Standard Therapy Germany 63
6454 Apheresis Autologous Mantle Cell Lymphoma Hematology 2015 Standard Therapy Germany 58
6455 Apheresis Autologous Mantle Cell Lymphoma-Relapse Hematology 2015 Standard Therapy Germany 66
6456 Apheresis Allogeneic Morbus Hodgkin Hematology 2015 Standard Therapy Germany 25
6457 Apheresis Allogeneic Morbus Hodgkin Hematology 2015 Standard Therapy Germany 22
6458 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 58
6459 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 54
6460 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 62
6461 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 70
6462 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 69
6463 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 56
6464 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 75
6465 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 70
6466 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 60
6467 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 72
6468 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 56
6469 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 65
6470 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 37
6471 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 54
6472 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 29
6473 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 68
6474 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 50
6475 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 61
6476 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 69
6477 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 60
6478 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 72
6479 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 43
6480 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 53
6481 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 73
6482 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 66
6483 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 61
6484 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 70
6485 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 71
6486 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 62
6487 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 56
6488 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 74
6489 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 50
6490 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 51
6491 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 63
6492 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 53
6493 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 72
6494 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 48
6495 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 63
6496 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 60
6497 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 65
6498 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 71
6499 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 61
6500 Apheresis Autologous Multiple Myeloma Hematology 2015 Standard Therapy Germany 61